Ars Technica

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's mRNA flu shot earns FDA approval after rollercoaster reviewWorldPing

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

This is a short WorldPing brief. The full report was published by Ars Technica.

Read the full report at Ars Technica

Related news

Le Court wins stage six of Tour after mechanical failureWorldPing
BBC Sport

Le Court wins stage six of Tour after mechanical failure

Kimberley Le Court wins a sprint finish to seal victory in stage six of the Tour de France Femmes on Thursday, as Swiss rider Marlen Reusser holds on to the overall lead.

Brief by WorldPing · Original reporting by BBC Sport